{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:48:37Z","timestamp":1791863317143,"version":"4.3.4"},"reference-count":7,"publisher":"Societas Neurologica Japonica","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rinsho Shinkeigaku"],"published-print":{"date-parts":[[2012]]},"DOI":"10.5692\/clinicalneurol.52.503","type":"journal-article","created":{"date-parts":[[2012,7,27]],"date-time":"2012-07-27T05:01:01Z","timestamp":1343365261000},"page":"503-506","source":"Crossref","is-referenced-by-count":5,"title":["Myasthenia gravis complicated with optic neuritis showing anti-aquaporin 4 antibody: a case report"],"prefix":"10.5692","volume":"52","author":[{"given":"Tomoaki","family":"Tsujii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nachi","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Iwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3663","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"2) Kanazawa M, Shimohata T, Tanaka K, et al. Clinical features of patients with myasthenia gravis associated with autoimmune diseases. Eur J Neurol 2007;14:1403-1404.","DOI":"10.1111\/j.1468-1331.2007.01978.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"3) Somer H, Muller K, Kinnunen E. Myasthenia gravis associated with multiple sclerosis, epidemiological survey and immunological findings. J Neurol Sci 1989;89:37-48.","DOI":"10.1016\/0022-510X(89)90005-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"4) Isbister CM, Mackenzie PJ, Anderson D, et al. Co-occurrence of multiple sclerosis and myasthenia gravis in British Columbia. Mult Scler 2003;9:550-553.","DOI":"10.1191\/1352458503ms964oa"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5) Uzawa A, Mori M, Iwai M, et al. Association of anti-auaporin-4 antibody-positive neurolyelitis optica with myasthenia gravis. J Neurol Sci 2009;287:105-107.","DOI":"10.1016\/j.jns.2009.08.040"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01392.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"7) Kay CS, Scola RH, Lorenzoni PJ, et al. NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy. J Neurol Sci 2008;275:148-150.","DOI":"10.1016\/j.jns.2008.06.038"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2008.01172.x"}],"container-title":["Rinsho Shinkeigaku"],"original-title":["\u91cd\u75c7\u7b4b\u7121\u529b\u75c7\u3078\u306e\u80f8\u817a\u6458\u9664\u885323\u5e74\u5f8c\u306b\u767a\u75c7\u3057\u305f\u6297aquaporin 4\u6297\u4f53\u967d\u6027\u8996\u795e\u7d4c\u708e\u306e1\u4f8b"],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T20:04:50Z","timestamp":1621541090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/clinicalneurol\/52\/7\/52_503\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":7,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.5692\/clinicalneurol.52.503","relation":{},"ISSN":["0009-918X","1882-0654"],"issn-type":[{"value":"0009-918X","type":"print"},{"value":"1882-0654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}